A new preprint study suggests that Moderna’s COVID-19 vaccine may be significantly more effective against symptomatic disease from the delta variant compared to Pfizer-BioNTech’s vaccine, while the ...
NEW YORK, N.Y. — Pfizer announced Wednesday that data shows a third dose of its COVID-19 vaccine can “strongly” boost protection against the highly transmissible delta variant. The pharmaceutical and ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
There is a risk that the highly transmissible delta variant first identified in India could become the dominant strain in the U.S. if vaccination rates lag, Anthony Fauci, MD, director of the National ...
More than 12 million Americans have rolled up their sleeves for the Johnson & Johnson COVID-19 vaccine. Now, preliminary but promising data shows the single-shot vaccine appeared to work well against ...
SAN FRANCISCO -- Earlier in the pandemic, experts had hoped if we can get 75% of Americans vaccinated, we can contain the coronavirus. Thursday, we're at just over 50% vaccinated. But 75% is no longer ...
Once fully vaccinated, Pfizer-BioNTech’s and AstraZeneca’s COVID-19 vaccines are effective against B.1.617.2, a more transmissible variant first detected in India, the U.K.’s public health agency ...
Johnson & Johnson said Thursday that new data shows that its single-shot COVID-19 vaccine provides protection against the virus for at least eight months and effectively prevents infection from ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant — beyond the protection afforded by the standard two doses, suggests new data released by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback